Isis Biodynamic Company Profile

06:37 EST 12th December 2018 | BioPortfolio

News Articles [8 Associated News Articles listed on BioPortfolio]

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

US$ 1.5B Deal, PTV News: Apr 01, 2010

GSK and Isis to develop up to 6 drugs for rare and serious diseases

Cholesterol Hope, PTV News: Mar 18, 2010

Genzyme and Isis announce positive phase III trials for inherited high LDL drug

Eminence Organic Skin Care Gives Back with Two Leading Initiatives

NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Giving back is all in a day's work for the natural, organic and Biodynamic® professional skin care brand Read more...

News Headlines, PTV News: Apr 01, 2010

A look at today's forthcoming news stories: GSK and Isis in US$ 1.5B deal to develop rare disease drugs; sanofi changes direction towards biotechnology, and Glaxo gets approval for Avodart in combinat...

News Headlines, PTV News: Mar 18, 2010

A look at today's forthcoming news stories including Genzyme and Isis announcing positive trials for rare cholesterol condition; Novartis wins European approval for meningitis vaccine and the cannabis...

PTV News: Nov 18, 2009

Top stories on November 18th, 2009: Safety concerns and delays undermine positive Isis trials NICE rejects BMS and Novartis leukaemia drug NicOx raises US$ 150M to push osteoarthritis drug Action ...

Novosom: Strategies for a Novel Liposomal Delivery Company

In this exclusive interview, Fintan Walton talks to Elias Papatheodorou, CEO of novosom, about the company’s novel liposomal technology, and the potential applications of this technology. Elias expl...

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Injury and death during the ISIS occupation of Mosul and its liberation: Results from a 40-cluster household survey.

Measurement of mortality and injury in conflict situations presents many challenges compared with stable situations. However, providing information is important to assess the impact of conflict on pop...

Truck attack: Fear of ISIS and reminder of truck attacks in Europe as associated with psychological distress and PTSD symptoms.

Following an ISIS attack, the present study examined the association between psychological distress and severe stress symptoms with vulnerability variables: i.e. Physical proximity to the site of the ...

Can scalar timing explain variability in scanning patterns?

Why are scanning patterns so variable? Theory predicts that for prey species facing non-stalking predators scans to monitor predators should occur at fixed rather than unpredictable times. Yet, empiri...

Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.

Impaired short-interval intracortical inhibition (SICI) elicited by paired-pulse TMS (ppTMS) has emerged as one of the most consistent TMS findings in patients with schizophrenia. Reduction of SICI ha...

The effects of manipulating the inter-stimulus-interval on heat-evoked temporal summation of second pan across the age span.

This study examined the effects of inter-stimulus-interval (ISI) on heat-evoked temporal summation of second pain (TSSP) and tested whether greatest maintenance of TSSP would occur at longer ISIs in o...

Clinical Trials [54 Associated Clinical Trials listed on BioPortfolio]

A Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of ISIS 353512, to evaluate the blood concentration and rate elimination of ISIS 353512 fr...

Dose-Escalating Safety Study in Subjects on Stable Statin Therapy

The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.

Study of ISIS 301012 in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as add-on therapy in subjects with Heterozygous Familial Hypercholesterolemia

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwis...

A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

The primary objective of the study is to examine the efficacy of multiple doses of ISIS SMNRx (ISIS 396443) administered intrathecally in preventing or delaying the need for respiratory in...

Companies [15 Associated Companies listed on BioPortfolio]

Isis Biodynamic

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Isis Parenting Inc.

Isis Parenting is the nation’s leading provider of prenatal and early parenting education. Isis partners with leading healthcare institutions to offer over their patients ove...

Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc. (the "Company" or “Nuo”) is a biomedical company that pioneers leading-edge biodynamic therapies for wound care. The Company's flagship product, A...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Isis Biodynamic" on BioPortfolio

We have published hundreds of Isis Biodynamic news stories on BioPortfolio along with dozens of Isis Biodynamic Clinical Trials and PubMed Articles about Isis Biodynamic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Isis Biodynamic Companies in our database. You can also find out about relevant Isis Biodynamic Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record